LINDSAY KNOX: Open Payments
NPI 1336910074 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 30 payments from 15 companies in 2025. Trend: 2023 $225 · 2024 $1,399 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $153 |
| PFIZER INC. | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Caris MPI, Inc. | 2 | $55 |
| Celgene Corporation | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Janssen Biotech, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
Products named: SCEMBLIX, KEYTRUDA, NINLARO, MI CANCER SEEK, BOSULIF, REBLOZYL, LUTATHERA, XTANDI.
Industry payments across TN — which companies pay providers there.
